回复：肉毒杆菌毒素A膀胱逼尿肌内注射治疗难治性特发性逼尿肌过度活动症的疗效及并发症 - Suppr | 超能文献

Re: Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.

作者信息

Sahai Arun, Dowson Christopher, Khan Mohammad Shamim, Dasgupta Prokar

出版信息

BJU Int. 2008 Feb;101(4):515-6; author reply 516-7. doi: 10.1111/j.1464-410X.2008.07447_3.x.

DOI:10.1111/j.1464-410X.2008.07447_3.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Re: Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.

BJU Int. 2008 Feb;101(4):515-6; author reply 516-7. doi: 10.1111/j.1464-410X.2008.07447_3.x.

2

Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity.

BJU Int. 2007 Dec;100(6):1302-6. doi: 10.1111/j.1464-410X.2007.07186.x.

3

Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity.

BJU Int. 2008 Jul 25;102 Suppl 1:7-10. doi: 10.1111/j.1464-410X.2008.07827.x.

4

Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.

J Urol. 2006 Jul;176(1):177-85. doi: 10.1016/S0022-5347(06)00590-8.

5

Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.

J Urol. 2007 Mar;177(3):1011-4. doi: 10.1016/j.juro.2006.10.047.

6

[Botulinum toxin type A in patients with overactive bladder].

Urologiia. 2010 May-Jun(3):36-40.

7

Re: Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.

J Urol. 2007 Feb;177(2):796-7; author reply 797. doi: 10.1016/j.juro.2006.09.089.

8

A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity.

BJU Int. 2006 Feb;97(2):413. doi: 10.1111/j.1464-410X.2006.06081_1.x.

9

Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.

Eur Urol. 2008 Jun;53(6):1253. doi: 10.1016/j.eururo.2008.02.038. Epub 2008 Mar 7.

10

What a patient with refractory idiopathic detrusor overactivity should know about botulinum neurotoxin type a injection.

J Urol. 2009 Apr;181(4):1773-8. doi: 10.1016/j.juro.2008.11.110. Epub 2009 Feb 23.

引用本文的文献

1

Repeated botulinum toxin type A (Dysport) injections for women with intractable detrusor overactivity: a prospective outcome study.

Int Urogynecol J. 2014 May;25(5):601-5. doi: 10.1007/s00192-013-2228-2. Epub 2013 Oct 17.

2

Women's perspective of botulinum toxin treatment for overactive bladder symptoms.

Int Urogynecol J. 2011 Apr;22(4):425-31. doi: 10.1007/s00192-010-1315-x. Epub 2010 Nov 24.